ACBD5 and epilepsy: Of note, many seizure-related genes identified in this study (for e.g. ACBD5, SLC6A5, STUB1) are not included in the routine epilepsy panel (R59) and this highlights the benefit of the gene-agnostic analytic approach offered by the rapid WES testing.